Italy Archives

News and Trends 19 Sep 2016

Italian Gene Therapy Biotech aims high by Collaborating with US Giant Amgen

Genenta Science and Amgen have teamed up to develop gene therapies for cancer. The Italian biotech from Milan raised €10M in series A funding last year and is already getting ready for clinical trials. Genenta is developing a gene therapy platform for haematopoietic stem cells and wants to bring it to the clinic. Together with the San Raffaele Hospital and Scientific […]

September 19, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

gsk strimvelis gene therapy price commercialization

News and Trends 16 Aug 2016

GSK Pioneers Money Back Guarantee for Biotech Treatments

The second-ever gene therapy to get European approval finally has a price tag. It will be sold at ‘only’ €594k, but with a twist – it has a money-back guarantee. Could this strategy finally get gene therapies some sales action? In May, GSK finally got European approval for a gene therapy, after sparking the resurgence […]

August 16, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 29 Jul 2016

Philogen targets Angiogenesis for cancer and Autoimmune Therapies

Barcelona was pleasant but once again it’s time to go away! We won’t go far… we’re just crossing the Balearic sea to the shores of Italy and visit Sovicille, a suburban town not far from Sienna, where Swiss-Italian company Philogen, our Biotech of the Week, is based! City: Sovicille (Italy) Founded: 1996 Employees: 70 Financial Data: N/A CEO: Duccio […]

July 29, 2016 - 2 minutesmins - By Joachim Eeckhout

molmed graft host disease zalmoxis leukemia

News and Trends 28 Jun 2016

Will the Leading Italian Biotech soon have its First Cell therapy on the Market?

MolMed has received conditional market approval for Zalmoxis, an ex vivo genetically engineered cell therapy that stops immune rejection of transplanted hematopoietic stem cells. This is a big step forward in a key treatment for blood cancers. A transplant of hematopoietic stem cells (cells that give origin to blood cells) is often used as part of treatments for […]

June 28, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 13 Jun 2016

Italy cures Diabetes with new Engineered Mini-organs

Ospedale Niguarda Ca’ Granda has succeeded in treating a patient with type 1 diabetes, using a new tissue engineering techniques for more effective islet transplants – something that could bring this diabetes cure to more patients. Biotech is tackling diabetes from several fronts – from mitigation of symptoms, for example, Avita’s skin spray, to medtech inventions […]

June 13, 2016 - 3 minutesmins - By Denise Neves Gameiro

gene therapy strimvelis biotech gsk offerele ada scid child

News and Trends 1 Jun 2016

EMA approves Groundbreaking Gene Therapy for Super Rare ‘Bubble Baby’ Disease

GSK, Fondazione Telethon and Ospedale San Raffaele have announced that the EMA has approved Strimvelis for a super rare immunodeficiency disease in Children. Following 20 years of research at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) in Italy, this is the news patients have been waiting for. Strimvelis is the first ex vivo stem cell gene […]

June 1, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 17 May 2016

New Italian Drug is FDA approved for trials in Rare Neurological Disease

Newron sees its Investigational New Drug application approved by the FDA. It can now begin clinical trials for Rett Syndrome patients – a rare neurological disorder. Based near Milan (Italy), Newron is a Biopharma developing therapies for diseases of the central nervous system (CNS). Last year it raised over €23M to advance its pipeline, which features candidates […]

May 17, 2016 - 2 minutesmins - By Denise Neves Gameiro

vatican stem cell research pope biotech biotechnology soon shiong patrick joe biden president

News and Trends 2 May 2016

What’s the Vatican doing with Biotech? Awarding Billionaire Doctors for Cancer & Stem Cell Research

Were you aware of the Vatican’s work in the Biosciences – including Biotech? Well, now it has awarded the Richest Doctor in the world, Patrick Soon-Shiong, some fancy award for his pioneering work against Cancer. AND it held an Adult stem cell therapy research conference with the Pope and US Vice President Joe Biden over the weekend. […]

May 2, 2016 - 4 minutesmins - By Dani Bancroft

txcell ospedale san raffaele lupus nephritis car treg

News and Trends 27 Apr 2016

CAR-T for Lupus with French-Italian Partnership

TxCell and Ospedale San Raffaele have partnered up to research a new treatment for Lupus, based on engineered regulatory T-cells (CAR-Treg). TxCell is developing immunotherapies based on the discovery of a type of T-cells that have anti-inflammatory properties – regulatory T lymphocytes (Tregs). Tregs have already yielded two candidates. Osave is currently on phase IIb […]

April 27, 2016 - 2 minutesmins - By Denise Neves Gameiro

innovators bioupper biotech evarplanning panoxyvir wrap italy startuP biotech accelerator bioupper

News and Trends 12 Apr 2016

What sort of Biotech Startups are coming out of Italy at the moment?

BioUpper in Milan has launched the first acceleration platform for new entrepreneurs in the field of biotech and Medicine. Here are 3 of the winners awarded €50,000 each in funding. The project is funded by Novartis and Fondazione Cariplo – the Italian cultural and Scientific grant foundation now worth over €8Bn. The aim of the project is to enhance promising projects and finance […]

April 12, 2016 - 4 minutesmins - By Joachim Eeckhout

News and Trends 1 Apr 2016

Biotech of the Week: MolMed, Immuno-oncology made in ‘Milano’

From one fashion capital to the other, this week we leave Paris and head down to Milan. Home to some worldwide high-fashion brands, Da Vinci’s Last Supper mural and main city of the Lombardy region, Milan is also where MolMed, our Biotech of the Week, is based. City: Milan (Italy) Founded: 1996 Employees: (+/-) 120 (as of 12/2015) […]

April 1, 2016 - 1 minutemin - By Joachim Eeckhout

italy milano gfbiochemicals levulinic acid petroleum chemicals biofuels pisa segetis

News and Trends 11 Mar 2016

Interview: Can this Natural Acid replace Petroleum for the Chemical and Biofuel Industries?

GFBiochemicals in (Italy) is producing levulinic acid (from breakdown of biomass) to replace petroleum-based products for a huge range of sectors, with up to a $30Bn market volume. We had the chance to meet Marcel Van Berkel, the CMO of GFBiochemicals, which is based in Milan with additional Netherlands and Minnesota (US) sites. Berkel told us more about the many […]

March 11, 2016 - 4 minutesmins - By Marie Godar

Resources

Categories

The biggest private biotech investments in August 2024

Long non-coding RNAs: what’s behind the growing “dark genome” buzz?

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Six biotech companies that could revolutionize obesity treatments

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us